Device Thrombogenicty Emulator (DTE) – Design optimization Methodology for Cardiovascular Devices: A Study in Two Bileaflet MHV Designs

Patients who receive prosthetic heart valve (PHV) implants require mandatory anticoagulation medication after implantation due to the thrombogenic potential of the valve. Optimization of PHV designs may facilitate reduction of flow-induced thrombogenicity and reduce or eliminate the need for post-im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xenos, Michalis, Girdhar, Gaurav, Alemu, Yared, Jesty, Jolyon, Slepian, Marvin, Einav, Shmuel, Bluestein, Danny
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922449/
https://ncbi.nlm.nih.gov/pubmed/20483411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiomech.2010.04.020
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge